Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on DAST. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Discover the novel synthesis of Seratrodast via patent CN100999452B. Achieve superior yields and cost reduction in API manufacturing with our scalable process.
Patent CN115850156A reveals a novel oxidation-based purification method for difluoro compounds, offering significant cost reduction and scalability for pharmaceutical intermediates.
Patent CN104341342B reveals high-yield DAST synthesis. Green solvent process ensures supply chain stability and cost efficiency for optical material manufacturing.
Patent CN102888227A discloses stable 1,1-difluorotetrahydronaphthalene compounds offering low threshold voltage and high charge retention for advanced TFT-LCD applications.
Novel synthesis route for Emedastine intermediate ensures >99% purity. Cost-effective manufacturing solution for reliable pharmaceutical intermediate supply chain partners.
Patent CN108863884A reveals mild DAST elimination route for nitroalkenes offering scalable production and reduced safety hazards for pharmaceutical intermediate manufacturing supply chains.
Patent CN104341342A reveals ethanol-based DAST synthesis yielding 95% purity. Offers supply chain stability and cost reduction for optoelectronic manufacturing.